WMSA
CYTK icon

Weiss Multi-Strategy Advisers’s Cytokinetics CYTK Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$1.67M – 128
2023
Q4 		$1.67M Buy
+20,000
New +$724K 0.04% 389
2014
Q2 		– Sell
-50,000
Closed -$475K – 762
2014
Q1 		$475K Buy
+50,000
New +$452K 0.01% 678

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CYTK Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Cytokinetics (CYTK) in Q1 2024, closing a stake of 24,286 shares — an estimated $2.03M sold.

Weiss Multi-Strategy Advisers first reported a position in CYTK in Q2 2013 and held it in 22 quarters. The position peaked at $2.26M in Q2 2023. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Cytokinetics position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 24,286 Cytokinetics shares in Q1 2024, an estimated $2.03M.
  • Weiss Multi-Strategy Advisers first reported a position in Cytokinetics in Q2 2013 and held it in 22 quarters.
  • Weiss Multi-Strategy Advisers's Cytokinetics position peaked at $2.26M in Q2 2023.
  • 390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.